RARE

Ultragenyx (RARE)

US
$ 40.295.11%

Price Chart

Key Statistics

Market Cap
$ 3.53B
P/E Ratio
0.00
Revenue (TTM)
$ 590.69M
Volume
668.63K
52W High
$ 60.37
52W Low
$ 29.59
Dividend Yield
0.00%
Beta
0.34

Technicals

50-Day MA
36.6162
200-Day MA
45.8931
52 Week High
60.37
52 Week Low
29.59

About RARE

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare g.

Employees
1294
Headquarters
Novato, CA
CEO
Dr. Emil D. Kakkis M.D., Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg